A detailed history of Azzad Asset Management Inc /Adv transactions in Repligen Corp stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 20,725 shares of RGEN stock, worth $3.02 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
20,725
Previous 20,824 0.48%
Holding current value
$3.02 Million
Previous $2.63 Billion 17.49%
% of portfolio
0.35%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$119.79 - $167.35 $11,859 - $16,567
-99 Reduced 0.48%
20,725 $3.08 Billion
Q2 2024

Jul 30, 2024

BUY
$120.0 - $182.95 $2,040 - $3,110
17 Added 0.08%
20,824 $2.63 Billion
Q1 2024

Apr 19, 2024

SELL
$170.78 - $208.42 $17,761 - $21,675
-104 Reduced 0.5%
20,807 $3.83 Billion
Q4 2023

Apr 01, 2024

BUY
$114.17 - $185.35 $272,523 - $442,430
2,387 Added 12.89%
20,911 $3.76 Billion
Q3 2023

Apr 01, 2024

BUY
$138.78 - $176.51 $613,962 - $780,880
4,424 Added 31.38%
18,524 $2.95 Billion
Q2 2023

Apr 01, 2024

BUY
$138.42 - $180.31 $332,623 - $433,284
2,403 Added 20.54%
14,100 $1.99 Billion
Q1 2023

Apr 01, 2024

BUY
$154.26 - $198.1 $49,208 - $63,193
319 Added 2.8%
11,697 $1.97 Billion
Q4 2022

Apr 01, 2024

BUY
$162.42 - $220.56 $273,515 - $371,423
1,684 Added 17.37%
11,378 $1.93 Billion
Q2 2022

Apr 01, 2024

BUY
$140.68 - $188.02 $271,793 - $363,254
1,932 Added 24.89%
9,694 $1.57 Billion
Q1 2022

Apr 01, 2024

BUY
$161.19 - $257.96 $648,144 - $1.04 Million
4,021 Added 107.48%
7,762 $1.46 Billion
Q4 2021

Apr 01, 2024

BUY
$247.59 - $304.47 $321,867 - $395,811
1,300 Added 53.26%
3,741 $991 Million
Q2 2021

Apr 01, 2024

BUY
$165.87 - $220.95 $404,888 - $539,338
2,441 New
2,441 $487 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.